Armata Pharmaceuticals, Inc. (ARMP) vs Humacyte, Inc. (HUMA)
- Armata Pharmaceuticals, Inc. ARMP 3.37 +9.06%
- Humacyte, Inc. HUMA 0.43 −2.27%
Armata Pharmaceuticals, Inc. and Humacyte, Inc. are both Biotechnology companies. Armata Pharmaceuticals, Inc. and Humacyte, Inc. are of similar size ($122.1M and $114.9M). Humacyte, Inc. grew revenue faster over the last twelve months: 149.8% against −19.3%. Armata Pharmaceuticals, Inc. has the higher net margin (−3,467.0% vs −4,448.9%) and the higher return on invested capital (−89.6% vs −433.7%). Across the 16 metrics below, Armata Pharmaceuticals, Inc. leads on 10 and Humacyte, Inc. on 6.
Valuation
Profitability
| Metric | ARMP | HUMA | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | (494.58%) | 65.16% |
| Operating margin | (734.19%) | (5,240.78%) | 0.00% |
| Net margin | (3,467.04%) | (4,448.89%) | 0.00% |
| Free cash flow margin | (465.34%) | (4,599.72%) | 0.00% |
| Return on equity | 127.83% | (534.42%) | (56.36%) |
| Return on assets | (225.11%) | (68.16%) | (48.04%) |
| Return on invested capital | (89.61%) | (433.66%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack